#Gilead's Hepcludex was the first drug to be cleared in the US for #hepatitisD in May, but a potential rival from #MirumPharma is already looming.
@pharmaphorum.bsky.socialExplore
@pharmaphorum.bsky.social
@ihieurope.bsky.social🏥 Our @viromarkers.bsky.social project is shedding new light on the role of viral proteins in untreated chronic #HepatitisD in a bid to advance the development of new, effective treatments.
